Table 2 Walking intervention for people with recurrent or metastatic cancer: questionnaire measures by assessment point
Measures included in the study questionnaire | Assessment point | |||
|---|---|---|---|---|
Description | T0 (Baseline) | T1 (6 weeks)1 | T2 (12 weeks)1 | T3 (24 weeks)1 |
Functional assessment of cancer therapy- general (FACT-G) [18] | ✓ | ✓ | ✓ | ✓ |
• Assesses emotional and physical quality of life in the past 7 days | ||||
Depression, anxiety, stress scales - 21 (DASS-21) [19] | ✓ | ✓ | ✓ | ✓ |
• Assesses the frequency and severity of symptoms over the past 7 days | ||||
General practice physical activity questionnaire (GPPAQ) [20] | ✓ | ✓ | ✓ | ✓ |
• Assesses physical activity levels (classified as active, moderately active, moderately inactive, inactive) in the past 7 days | ||||
Scottish physical activity questionnaire (SPAQ) [21] | ✓ | ✓ | ✓ | ✓ |
• Captures 7-day recall of all leisure and occupational physical activity | ||||
Spinal cord injury exercise self-efficacy scale (ESES) [22] | ✓ | ✓ | ✓ | ✓ |
• Assesses current exercise self-efficacy | ||||
Brief fatigue inventory (BFI) [23] | ✓ | ✓ | ✓ | ✓ |
• Assesses severity of fatigue and any impact on functioning in the previous 24 hours | ||||
Eastern Cooperative Oncology Group (ECOG) [24] | ✓ | ✓ | ✓ | ✓ |
• Measures current performance status, how disease is progressing and affects daily living activities | ||||
Motivational ruler [25] | ✓ | ✓ | ✓ | ✓ |
• Includes two visual 100 mm visual analog scales to measure current importance and confidence in walking | ||||
Patient reported demographics and clinical history | ✓ | |||
• Study specific measure includes sex, age, marital status, education, long-standing health conditions etc. | ||||
Adverse outcomes and events (intervention only) | ✓ | ✓ | ||
End of study questionnaire | ✓ | |||
• Effects on quality of life (intervention only); usefulness of information; achievement of physical activity goals; satisfaction with study/intervention; free text comments about the study | ||||